Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer

Tremendous progress has been achieved in the field of immune checkpoint inhibitors (ICIs) therapy in lung cancer in recent years. To generate robust, long-lasting anti-tumor immune responses in lung cancer patients, combinational ICI therapies have been explored deeply. Conventionally, chemotherapy...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Onco Targets Ther
Autori principali: Liu, Wei, Zhang, Lei, Xiu, Zhiming, Guo, Jian, Wang, Liye, Zhou, Yue, Jiao, Yang, Sun, Meiyan, Cai, Jianhui
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2020
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7394580/
https://ncbi.nlm.nih.gov/pubmed/32801752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S255491
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi